Drug and Medical Device Safety: Leveraging Customs for Product Safety (Podcast 4 of 4)

The Global Pharmaceutical Center presents a series of four podcasts that delve deep into issues from Progressions 2007, The Ernst & Young Global Pharmaceutical Report. By registering for this series, you'll have access to each podcast as it is released.

Podcast 4 - Leveraging Customs for Patient Safety

Building a strong relationship with Customs authorities is indispensable in helping manufacturers and other intellectual property owners improve their supply chain performance and act effectively against counterfeit products at an operational level. Companies seeking to broaden their options for combating counterfeits should explore regional and country-specific security programs. These programs will help strengthen a company´s brand protection framework, potentially intercept harmful counterfeits, and provide long term benefits that ensure continued international supply chain efficiency.


Other Webcasts & Podcasts

The Obama administration and the new Congress:

Good medicine for the pharma, biotech, and medtech industries?

February 20, 2009

image

Released on:
Monday, October 15, 2007

(n/a
n/a your local time)

Duration: 16 minutes

Note: the webcast technology is not compatible with the browser you are using. Use Internet Explorer or Firefox.

Ernst & Young refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global Ernst & Young organization and does not provide any services to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms.